CJ Bioscience
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
311690 | KO
Overview
Corporate Details
- ISIN(s):
- KR7311690002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 중구 세종대로 14 그랜드센트럴타워 B동 7층, 중구
- Website:
- https://www.cjbioscience.com/en/
Description
CJ Bioscience is a company focused on developing microbiome-based therapeutics to address unmet medical needs. It utilizes a proprietary AI-powered drug discovery platform, Ez-Mx®, to identify and advance novel live biotherapeutic products (LBPs). The company's primary focus is on creating treatments for complex diseases, with a pipeline targeting oncology and inflammatory bowel disease (IBD). Key candidates include CJRB-101, its lead oncology asset, and CJRB-201, a promising oral therapeutic for IBD that has demonstrated significant anti-inflammatory efficacy in preclinical models. In addition to its drug development programs, CJ Bioscience provides next-generation sequencing (NGS) and bioinformatics solutions to the global research community through its EzBioCloud platform.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-09-02 00:00 |
증권발행결과(자율공시)(제1회차 CB)
|
Korean | 5.9 KB | ||
| 2020-08-31 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 40.5 KB | ||
| 2020-08-14 00:00 |
반기보고서 (2020.06)
|
Korean | 1.1 MB | ||
| 2020-07-16 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 74.0 KB | ||
| 2020-05-15 00:00 |
분기보고서 (2020.03)
|
Korean | 1.0 MB | ||
| 2020-05-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.4 KB | ||
| 2020-05-07 00:00 |
[기재정정]주식매수선택권행사
|
Korean | 20.1 KB | ||
| 2020-05-06 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.5 KB | ||
| 2020-04-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2020-04-28 00:00 |
주식매수선택권행사
|
Korean | 16.7 KB | ||
| 2020-04-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.4 KB | ||
| 2020-04-02 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 10.3 KB | ||
| 2020-03-31 00:00 |
[기재정정]사업보고서 (2019.12)
|
Korean | 1.4 MB | ||
| 2020-03-31 00:00 |
타법인주식및출자증권취득결정(자율공시)
|
Korean | 17.2 KB | ||
| 2020-03-30 00:00 |
사업보고서 (2019.12)
|
Korean | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all CJ Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CJ Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CJ Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
